Seaport Therapeutics Expands Executive Team with Key Appointments
Key Highlights Antony Loebel, M.D., appointed as Chief Medical Officer and President of Clinical Development. Lana Gladstein, J.D.,…
Browsing Tag
APRINOIA Therapeutics
1 post